{"id":"https://openalex.org/W4239142255","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps2621","title":"Phase I study of procaspase activating compound-1 (PAC-1) for treatment of advanced malignancies.","display_name":"Phase I study of procaspase activating compound-1 (PAC-1) for treatment of advanced malignancies.","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W4239142255","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps2621"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.tps2621","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps2621","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps2621","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035708719","display_name":"Oana Cristina Danciu","orcid":"https://orcid.org/0000-0003-4487-9136","observed_orcids":["https://orcid.org/0000-0003-4487-9136"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Oana C. Danciu","raw_affiliation_strings":["University of Illinois at Chicago, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Illinois at Chicago, Chicago, IL;","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108660373","display_name":"Martin Kelly Nicholas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin Kelly Nicholas","raw_affiliation_strings":["University of Illinois at Chicago, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Illinois at Chicago, Chicago, IL;","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086594299","display_name":"Matthias Holdhoff","orcid":"https://orcid.org/0000-0002-3285-3484","observed_orcids":["https://orcid.org/0000-0002-3285-3484"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthias Holdhoff","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD;","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Richard A. Peterson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52792670","display_name":"HealthPartners","ror":"https://ror.org/03s9ada67","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I52792670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard A. Peterson","raw_affiliation_strings":["Health Partners, St Paul, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Partners, St Paul, MN;","institution_ids":["https://openalex.org/I52792670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076656358","display_name":"Theodore M. Tarasow","orcid":"https://orcid.org/0000-0003-0784-1219","observed_orcids":["https://orcid.org/0000-0003-0784-1219"]},"institutions":[{"id":"https://openalex.org/I4210132860","display_name":"Vanquish Oncology (United States)","ror":"https://ror.org/041khxm91","country_code":"US","type":"company","lineage":["https://openalex.org/I4210132860"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Theodore M Tarasow","raw_affiliation_strings":["Vanquish Oncology Inc, Champaign, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanquish Oncology Inc, Champaign, IL;","institution_ids":["https://openalex.org/I4210132860"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027996458","display_name":"Paul J. Hergenrother","orcid":"https://orcid.org/0000-0001-9018-3581","observed_orcids":["https://orcid.org/0000-0001-9018-3581"]},"institutions":[{"id":"https://openalex.org/I4210132860","display_name":"Vanquish Oncology (United States)","ror":"https://ror.org/041khxm91","country_code":"US","type":"company","lineage":["https://openalex.org/I4210132860"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul J. Hergenrother","raw_affiliation_strings":["Vanquish Oncology Inc, Champaign, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanquish Oncology Inc, Champaign, IL;","institution_ids":["https://openalex.org/I4210132860"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090069473","display_name":"Arkadiusz Zbigniew Dudek","orcid":"https://orcid.org/0000-0002-9114-8945","observed_orcids":["https://orcid.org/0000-0002-9114-8945"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arkadiusz Z. Dudek","raw_affiliation_strings":["University of Illinois at Chicago, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Illinois at Chicago, Chicago, IL;","institution_ids":["https://openalex.org/I39422238"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"TPS2621","last_page":"TPS2621"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.7559000253677368,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.7559000253677368,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.21850000321865082,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12582","display_name":"Flavonoids in Medical Research","score":0.004900000058114529,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pac-1","display_name":"PAC-1","score":0.8389999866485596},{"id":"https://openalex.org/keywords/caspase-3","display_name":"caspase-3","score":0.9919999837875366},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8600000143051147},{"id":"https://openalex.org/keywords/advanced-cancer","display_name":"advanced cancer","score":0.8360000252723694},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8289999961853027},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.8730000257492065},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9470000267028809},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6510000228881836},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.902999997138977},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.8019999861717224},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.5870000123977661},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.4740000069141388},{"id":"https://openalex.org/keywords/glioma","display_name":"glioma","score":0.4429999887943268},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.4580000042915344},{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":0.6620000004768372},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.3869999945163727}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8022757768630981},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.7123572826385498},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.6030651330947876},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5590234398841858},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5388798713684082},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5165016055107117},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5076862573623657},{"id":"https://openalex.org/C2780964509","wikidata":"https://www.wikidata.org/wiki/Q416975","display_name":"Dacarbazine","level":3,"score":0.46933355927467346},{"id":"https://openalex.org/C12519072","wikidata":"https://www.wikidata.org/wiki/Q14914370","display_name":"Caspase 3","level":4,"score":0.46359720826148987},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4551430344581604},{"id":"https://openalex.org/C98424977","wikidata":"https://www.wikidata.org/wiki/Q25805","display_name":"Caspase","level":4,"score":0.450838178396225},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39472535252571106},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37263160943984985},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34210261702537537},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.19537660479545593},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1323859989643097},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.tps2621","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps2621","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps2621","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2772817388","https://openalex.org/W2947743059","https://openalex.org/W2899662309","https://openalex.org/W2988750812","https://openalex.org/W2563054337","https://openalex.org/W2955003497","https://openalex.org/W3083426590","https://openalex.org/W2792287720","https://openalex.org/W2726121999","https://openalex.org/W7096800402"],"abstract_inverted_index":{"TPS2621":[0],"Background:":[1],"Dysregulation":[2],"in":[3,17,28,46,70,95,99,113,118,146,163,190,197,216,251],"apoptotic":[4,40],"pathways":[5],"is":[6,68,180,195,221,272,293,307,323,331,338],"a":[7,21,75,81],"hallmark":[8],"feature":[9],"of":[10,23,38,66,79,87,144,156,210,230,281,315],"cancer,":[11],"offering":[12],"opportunities":[13],"for":[14,299,321,329],"pharmacologic":[15],"intervention":[16],"its":[18],"treatment.":[19],"Caspases,":[20],"family":[22],"proteases,":[24],"play":[25],"several":[26],"roles":[27],"apoptosis.":[29],"Caspase-3":[30,42],"catalyzes":[31,84],"the":[32,39,64,85,134,139,149,154,187,201,225,252,289],"intra-cellular":[33],"proteolysis":[34],"that":[35,83],"characterizes":[36],"part":[37],"process.":[41],"levels":[43],"are":[44],"low":[45],"many":[47],"tumors":[48],"including:":[49],"glioblastoma;":[50],"breast,":[51],"colon,":[52],"lung,":[53],"and":[54,59,117,208,234,265,328],"liver":[55],"cancers:":[56],"lymphoma:":[57],"neuroblastoma;":[58],"melanoma.":[60],"In":[61,101],"contrast,":[62],"procaspase-3,":[63],"precursor":[65],"caspase-3":[67],"elevated":[69],"these":[71],"tumors.":[72],"We":[73],"describe":[74],"phase":[76],"I":[77,127],"study":[78,130,337],"PAC-1,":[80],"drug":[82,258],"conversion":[86],"procaspase":[88],"-3":[89],"to":[90,137,152,183,301,319,340],"caspase-3.":[91],"It":[92],"induces":[93],"apoptosis":[94],"tumor":[96,217],"cell":[97],"lines":[98],"vitro.":[100],"vivo":[102],"activity":[103,212],"has":[104,131],"also":[105],"been":[106],"shown,":[107],"when":[108,158],"combined":[109,159],"with":[110,121,160,165,213,257,297],"alkylating":[111],"chemotherapy,":[112],"rodent":[114],"glioma":[115],"models":[116],"canines":[119],"diagnosed":[120],"malignant":[122],"glioma.":[123],"Methods:":[124],"This":[125],"Phase":[126],"dose":[128,142,292],"escalation":[129,300],"two":[132],"components:":[133],"first":[135,202,290],"(C1)":[136,233],"determine":[138,153],"maximum":[140],"tolerated":[141],"(MTD)":[143],"PAC-1":[145,157,193,211,269,291],"advanced":[147,231],"malignancies;":[148],"second":[150],"(C2)":[151],"MTD":[155,188],"temozolomide":[161],"(TMZ)":[162],"patients":[164],"recurrent":[166,235],"anaplastic":[167],"astrocytoma":[168],"(AA)":[169],"or":[170,237,260],"glioblastoma":[171],"(GBM).":[172],"A":[173],"modified":[174],"Fibonacci":[175],"3":[176,178],"+":[177],"design":[179],"used,":[181],"expanding":[182],"nine":[184],"subjects":[185,199],"at":[186,274,309],"level":[189,326,334],"each":[191,282,316],"component.":[192],"pharmacokinetics":[194],"assessed":[196],"all":[198],"during":[200],"cycle.":[203,285,317],"Secondary":[204],"objectives":[205],"include":[206],"pharmacodynamics":[207],"correlations":[209],"procaspase-3":[214],"expression":[215],"tissue.":[218],"Neurologic":[219],"toxicity":[220],"closely":[222],"monitored":[223],"throughout":[224],"study.":[226],"Inclusion":[227],"criteria:":[228,247],"diagnoses":[229],"malignancies":[232],"AA":[236],"GBM":[238],"(C2),":[239],"ECOG":[240],"PS":[241],"0-2,":[242],"adequate":[243],"organ":[244],"function.":[245],"Exclusion":[246],"prior":[248],"cytotoxic":[249],"therapy":[250],"last":[253],"3-6":[254],"weeks":[255],"(varying":[256],"class)":[259],"uncontrolled":[261],"chronic":[262],"illness.":[263],"Administration":[264],"design:":[266],"For":[267,286],"C1,":[268],"(orally":[270],"administered)":[271],"dosed":[273,308],"75-1,000":[275],"mg":[276,295,303],"daily":[277,296],"on":[278],"days":[279,313],"1-21":[280],"28":[283],"day":[284],"C":[287],"2,":[288],"375":[294],"potential":[298],"1,000":[302],"daily.":[304],"TMZ,":[305],"PO,":[306],"150":[310],"mg/m2":[311],"daily,":[312],"8-12,":[314],"Enrollment":[318],"date":[320],"C1":[322],"27,":[324],"(dose":[325,333],"6);":[327],"C2":[330],"4":[332],"1).":[335],"The":[336],"open":[339],"accrual.":[341],"Clinical":[342],"trial":[343],"information:":[344],"NCT02355535.":[345]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2022-05-12T00:00:00"}